SuperworthKrystal Biotech shares outstanding KRYS
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 30.7M
- On a year earlier
- +3.1%
- more shares
Krystal Biotech had 30.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 30.3M | +1% |
| FY2024 | 30M | +4% |
| FY2023 | 28.8M | +12% |
| FY2022 | 25.7M | +11% |
| FY2021 | 23.1M | +17% |
| FY2020 | 19.7M | +14% |
| FY2019 | 17.3M | +28% |
| FY2018 | 13.5M | +33% |
| FY2017 | 10.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 30.7M | +3% | |
| Q1 FY26 | 30.5M | +2% | |
| Q4 FY25 | 30.3M | +1% | |
| Q3 FY25 | 29.8M | −0% | |
| Q2 FY25 | 29.7M | +0% | |
| Q1 FY25 | 29.9M | +2% | |
| Q4 FY24 | 30M | +4% | |
| Q3 FY24 | 29.9M | +3% | |
| Q2 FY24 | 29.6M | +11% | |
| Q1 FY24 | 29.3M | +14% | |
| Q4 FY23 | 28.8M | +12% | |
| Q3 FY23 | 28.9M | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Krystal Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.